Revolution Medicines Inc (RVMD) concluded trading on Wednesday at a closing price of $48.25, with 7.16 million shares of worth about $345.35 million changed hands on the day. Half year performance of the stock remained positive as price took a surge of 18.61% during that period and on December 04, 2024 the price saw a gain of about 0.04%. Currently the company’s common shares owned by public are about 167.75M shares, out of which, 141.01M shares are available for trading.
Stock saw a price change of -17.70% in past 5 days and over the past one month there was a price change of -13.64%. Year-to-date (YTD), RVMD shares are showing a performance of 68.24% which increased to 99.13% when we look at its performance for past 12 months. Over the period of past 52 weeks, stock dropped to lowest price of $23.38 but also hit the highest price of $62.40 during that period. The average intraday trading volume for Revolution Medicines Inc shares is 1.32 million. The stock is currently trading -14.73% below its 20-day simple moving average (SMA20), while that difference is down -7.11% for SMA50 and it goes to 14.93% higher than SMA200.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Revolution Medicines Inc (NASDAQ: RVMD) currently have 167.75M outstanding shares and institutions hold larger chunk of about 88.62% of that.
The stock has a current market capitalization of $8.12B and its 3Y-monthly beta is at 1.42. It has posted earnings per share of -$3.59 in the same period. It has Quick Ratio of 14.24 while making debt-to-equity ratio of 0.06. Volatility of a stock is a metric used to know how much the price of that stock is under influence and for RVMD, volatility over the week remained 6.04% while standing at 4.27% over the month.
Stock’s fiscal year EPS is expected to rise by 9.70% while it is estimated to decrease by -15.28% in next year.
Digging deeper we find that several firms have released their research notes about the support levels of the stock. Most recent of them is a note released by Needham on July 16, 2024 offering a Buy rating for the stock and assigned a target price range of between $46 and $62 to it. Coverage by Barclays stated Revolution Medicines Inc (RVMD) stock as an Overweight in their note to investors on July 12, 2024, suggesting a price target of $52 for the stock. On July 08, 2024, Jefferies Initiated their recommendations, while on April 12, 2024, Needham Reiterated their ratings for the stock with a price target of $46. Stock get a Strong buy rating from Raymond James on April 10, 2024.
